Molbio Diagnostics Limited (NSEI: MOLBIO)
Health Care · Health Care Equipment & Supplies · IN
Rs1,484.10
-0.15% today · +42.5% 1Y
Molbio Diagnostics Limited (NSEI: MOLBIO) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $1.82B and employs 1,225 people.
Over the last twelve months the share price has gained 42.5%, trading between 926.35 and 1.69K.
Tweenvest scores Molbio Diagnostics Limited across four factors: quality 76/100, value 16/100. Its strongest factor is quality.
MOLBIO price history
Key figures
- Market cap
- $1.82B
- Revenue (TTM)
- $149.46M
- P/E
- 108.74
- EPS
- 14.77
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs1,686.80
- 52-week low
- Rs926.35
- Avg volume (3M)
- —
- Shares outstanding
- 115.24M
- Employees
- 1,225
- Next earnings
- —
About Molbio Diagnostics Limited
Molbio Diagnostics Limited, a point-of-care diagnostics company, provides healthcare technologies to diagnose infectious and non-communicable diseases. It manufactures and sells chip based diagnostic devices, chips and reagents, X-ray equipment's, and single/dual detectors. It also offers disposable POCT devices, which includes dengue, malaria, and COVID-19 tests; Tabletop analysers, a portable machine that are used to perform molecular or immunodiagnostic tests to detect infectious diseases, such as tuberculosis, human papillomavrus, STIs, and GI disorders. In addition, the company offers Truenat, a multi-disease real-time polymerase chain reaction platform that enables treatment decisions for various infectious and non-communicable diseases, such as tuberculosis, human immunodeficiency virus, malaria, viral hepatitis, COVID-19, dengue, chikungunya, influenza, H1N1, HPV/cervical cancer, cholera, leprosy, etc.; and Truenat assays. The company was incorporated in 2000 and is based in Verna, India.
- ISIN
- INE869T01028
- Founded
- 2000
- Listed since
- Aug 17, 2026
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Drägerwerk AG & Co. KGaAXTRA: DRW3 | $2.09B | €116.00 | -2.52% |
| Establishment Labs Holdings Inc.NasdaqCM: ESTA | $2.08B | $69.61 | -1.68% |
| MeHow Innovative Ltd.SZSE: 301363 | $1.95B | CN¥16.35 | -2.74% |
| Shandong Weigao Group Medical Polymer Company LimitedSEHK: 1066 | $1.82B | HK$3.15 | -0.79% |
| Poly Medicure LimitedBSE: 531768 | $1.81B | Rs1,668.55 | +0.95% |
| Shandong Pharmaceutical Glass Co.LtdSHSE: 600529 | $1.80B | CN¥18.11 | +1.40% |
| Top Glove Corporation Bhd.KLSE: TOPGLOV | $1.79B | RM0.91 | -1.62% |
| LeMaitre Vascular, Inc.NasdaqGM: LMAT | $1.71B | $74.86 | -0.95% |